News

Featured News

  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • News | December 16, 2021

    Verge Genomics Secures $98 Million in New Financing

    Read More

    Press Release | December 9, 2021

    Interius BioTherapeutics Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform

    Read More

    News | December 1, 2021

    Entrada Therapeutics: Advancing A New Class Of Medicines Called EEV

    Read More

    News | December 1, 2021

    Cyrus Biotechnology

    Read More

    News | December 1, 2021

    Zenas BioPharma

    Read More

    Press Release | November 23, 2021

    Dragonfly Announces Merck Opt-In on Second TriNKET

    Read More

    News | November 12, 2021

    ImCheck Provides Promising Updated Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at SITC Meeting 2021

    Read More

    News | October 20, 2021

    imCheck Publishes Comprehensive Overview of the Developmenet Resumts of its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Cells in Science Translational Medicine

    Read More

    Press Release | October 18, 2021

    Dragonfly Therapeutics Announces Sixth Dragonfly Drug to be Licensed by Bristol Myers Squibb and Receipt of Milestone Payments Following First Patient Dosing of Two TriNKET™ Immunotherapies

    Read More

    Press Release | October 13, 2021

    Agent Capital Adds Dr. John Orloff as Venture Partner

    Read More

    Press Release | October 11, 2021

    Pyxis IPO leads way as four life science firms kick off 4Q, raising nearly $500M

    Read More

    Press Release | October 8, 2021

    Pyxis Oncology Raises $168M in Upsized IPO

    Read More

    Press Release | October 8, 2021

    Precision BioSciences Statement on Safety of its Allogeneic CAR T Cells

    Read More

    Press Release | October 4, 2021

    New Study Finds Freenome’s Multiomics Approach Successful in Detecting Pancreatic Cancer

    Read More

    Press Release | October 4, 2021

    Research Highlights Freenome’s Blood Test for Colorectal Cancer to Primary Care Physicians

    Read More

    Press Release | October 1, 2021

    ImCheck to Present Updated Patient Response Data from the EVICTION Trial and Additional ICT01 Results at the SITC Annual Meeting 2021

    Read More

    News | September 28, 2021

    Orbus Therapeutics Granted European Patent for Method of Use for Eflornithine

    Read More

    News | September 17, 2021

    Skyhawk Therapeutics Completes New Investment Round

    Read More

    News | September 17, 2021

    DICE Therapeutics Announces Pricing of Upsized Initial Public Offering

    Read More

    News | September 17, 2021

    ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021

    Read More